Authors

Ingrid Laemmle-Ruff

MBBS, BMedSc, MPH, FAFPHM, FRACP, Public Health Physician and Paediatrician, Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children’s Research Institute, Melbourne, Vic; Paediatrician, Department of General Medicine, Royal Children’s Hospital, Melbourne, Vic

Respiratory syncytial virus prevention is finally here: An overview of safety

A summary of safety data on respiratory syncytial virus prevention products approved in Australia by the Therapeutic Goods Administration.